11/14/2024 6:14 PM | Lind Global Fund II LP (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
11/14/2024 11:39 AM | JANUS HENDERSON GROUP PLC (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 11:21 AM | CVI Investments, Inc. (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024 4:35 PM | Stonepine Capital Management, LLC (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024 7:15 AM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 8:32 AM | Adage Capital Management, L.P. (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
10/30/2024 3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
09/27/2024 7:14 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
09/12/2024 11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
09/12/2024 3:15 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
09/10/2024 4:19 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
08/30/2024 3:19 PM | Tenax Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/30/2024 3:20 PM | Tenax Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/23/2024 3:31 PM | Tenax Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
08/19/2024 5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
08/15/2024 3:19 PM | Stonepine Capital Management, LLC (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
08/14/2024 5:47 PM | Tenax Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/14/2024 2:19 PM | JANUS HENDERSON GROUP PLC (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
08/13/2024 3:45 PM | Tenax Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024 7:35 AM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 6:42 PM | Davidson Michael H. (Reporting) Tenax Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 6:43 PM | PROEHL GERALD T (Reporting) Tenax Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 6:23 AM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 4:00 PM | Giordano Christopher Thomas (Reporting) Tenax Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:01 PM | Rich Stuart (Reporting) Tenax Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 3:01 PM | Tenax Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 8:01 AM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 7:42 AM | Tenax Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024 7:50 AM | Tenax Therapeutics (Filer)
| Form ARS | |
04/26/2024 7:30 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 7:30 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/14/2024 11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/14/2024 11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/11/2024 3:56 PM | Tenax Therapeutics (Filer)
| Form POS AM | |
04/11/2024 3:59 PM | Tenax Therapeutics (Filer)
| Form POS AM | |
03/28/2024 1:02 PM | Tenax Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/28/2024 7:45 AM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/26/2024 3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/23/2024 3:30 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
02/21/2024 3:30 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/20/2024 7:33 AM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 10:28 AM | CVI Investments, Inc. (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
02/15/2024 6:36 PM | Lind Global Fund II LP (Filed by) Tenax Therapeutics (Subject)
| Form SC 13G | |
02/07/2024 8:01 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/07/2024 11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
02/06/2024 8:20 AM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/06/2024 7:56 AM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 4:24 PM | Tenax Therapeutics (Filer)
| Form S-1/A | |
01/22/2024 3:30 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
01/19/2024 3:30 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
01/12/2024 4:46 PM | HOFFMAN LAWRENCE R (Reporting) Tenax Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/12/2024 3:30 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
01/05/2024 3:46 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 3:57 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
12/01/2023 3:47 PM | Tenax Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/01/2023 3:01 PM | Tenax Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |